09 Jan China joins US and Japan in approving Alzheimer’s drug Leqembi developed by Eisai and Biogen
Posted at 22:00h
in Asia
China has approved a drug to treat Alzheimer’s, becoming only the third country after the US and Japan to fast track its sale to treat the irreversible and progressive brain disorder.The nation’s drugs regulator on Tuesday said Leqembi, an antibody that has shown to slow...